研究者詳細

顔写真

ヒガシ ケンジロウ
東 賢二郎
Kenjiro Higashi
所属
病院 感覚器・理学診療科 頭頸部外科
職名
講師
学位
  • 博士(医学) (東北大学)

e-Rad 研究者番号
30569546

経歴 9

  • 2023年11月 ~ 継続中
    東北大学 耳鼻咽喉・頭頸部外科 医師

  • 2021年1月 ~ 2023年10月
    東北大学 耳鼻咽喉・頭頸部外科 医師

  • 2018年4月 ~ 2020年12月
    岩手県立磐井病院 耳鼻咽喉科 科長

  • 2017年10月 ~ 2018年3月
    JCHO仙台病院 耳鼻咽喉科 医長

  • 2012年10月 ~ 2017年9月
    東北大学 耳鼻咽喉科・頭頸部外科

  • 2011年10月 ~ 2012年9月
    磐城共立病院 耳鼻咽喉科 医長

  • 2010年7月 ~ 2011年9月
    仙台市立病院 耳鼻いんこう科 医員

  • 2009年4月 ~ 2010年6月
    東北大学 病院(医科診療部門) 耳鼻咽喉・頭頸部外科 医員

  • 2007年4月 ~ 2009年3月
    秋田組合総合病院 研修医

︎全件表示 ︎最初の5件までを表示

学歴 2

  • 東北大学 医学系研究科 博士課程

    2014年4月 ~ 2018年3月

  • 山梨大学 医学部 医学科

    ~ 2007年3月

所属学協会 7

  • 日本クリニカルパス学会

    ~ 継続中

  • 日本静脈経腸栄養学会

    ~ 継続中

  • 日本癌治療学会

    ~ 継続中

  • 日本頭蓋底外科学会

    ~ 継続中

  • 日本頭頸部癌学会

    ~ 継続中

  • 日本頭頸部外科学会

    ~ 継続中

  • 日本耳鼻咽喉科頭頸部外科学会

    ~ 継続中

︎全件表示 ︎最初の5件までを表示

研究キーワード 2

  • 頭頸部癌

  • クリニカルパス

研究分野 2

  • ライフサイエンス / 医用システム / クリニカルパス

  • ライフサイエンス / 耳鼻咽喉科学 / 頭頸部癌

論文 37

  1. Acoustic analysis in the assessment of postoperative speech impairment in oral cancer patients. 国際誌

    Yutaro Saito, Takeshi Sato, Akira Ohkoshi, Ryo Ishii, Kenjiro Higashi, Ayako Nakanome, Jun Suzuki, Yukio Katori

    Oral and maxillofacial surgery 30 (1) 9-9 2025年12月20日

    DOI: 10.1007/s10006-025-01497-2  

    詳細を見る 詳細を閉じる

    PURPOSE: Acoustic analysis is an objective and quantitative method in diagnosing speech disorders and evaluating treatment efficacy. Although many reports have used acoustic analysis for oral cancer patients, few studies have focused on the extent of tongue resection. The aim of this study was to evaluate the usefulness of acoustic analysis in the assessment of postoperative speech impairment in oral cancer patients. METHODS: Postoperative speech data as well as Speech Handicap Index (SHI) and 5-point speech intelligibility scale were collected from 65 patients including 31 cases of oral cancer resection without glossectomy, 18 cases of partial glossectomy, and 16 cases of subtotal glossectomy. Speech data were acoustically analyzed by triangular vowel space area, vowel articulation index (VAI), first (F1) and second (F2) formant slopes, and compared according to the extent of tongue resection. RESULTS: The frequency of speech impairment assessed by SHI and 5-point speech intelligibility scale was differed according to the extent of tongue resection. As acoustic analysis, VAI and F1 slope in cases of subtotal glossectomy were significantly smaller than those in cases of partial glossectomy. F2 slope in cases of subtotal glossectomy was significantly smaller than those in the other cases. CONCLUSION: Acoustic analysis was potentially useful as an objective speech assessment for the patients who underwent oral cancer surgery.

  2. Treatment outcomes of definitive radiotherapy for unresectable salivary gland cancers: a multicenter, retrospective study in northern Japan. 国際誌

    Akira Ohkoshi, Ryo Ishii, Kenjiro Higashi, Tomonori Kambayshi, Satoshi Kano, Takahiro Kusaka, Daisuke Matsushita, Kosuke Murayama, Yuya Miyakura, Satoshi Kubota, Ryosuke Sato, Shino Godo, Hiroki Tomizawa, Satoshi Toyoma, Ai Tagawa, Akina Shirotori, Yukio Katori

    Japanese journal of clinical oncology 55 (12) 1342-1348 2025年12月3日

    DOI: 10.1093/jjco/hyaf147  

    詳細を見る 詳細を閉じる

    BACKGROUND: Treatment of unresectable salivary gland cancers is challenging. This multicenter, retrospective study aimed to evaluate the treatment outcomes of definitive radiotherapy, with or without chemotherapy, for locally advanced, unresectable, salivary gland cancers. METHODS: A total of 27 patients with unresectable salivary gland cancers who underwent concurrent chemoradiotherapy or radiotherapy with curative intent between 2012 and 2022 at 13 hospitals in northern Japan were included in this study. Overall survival (OS) and progression-free survival (PFS) were assessed, and factors affecting OS and PFS were identified through univariate and multivariate Cox regression analyses. The variables evaluated included age, sex, primary site, histological type, clinical T and N status, clinical stage, treatment type, and radiation type. RESULTS: Seven patients received concurrent chemoradiotherapy, and 20 patients received radiotherapy (6 photon, 11 proton, 3 heavy ion). With a median follow-up period of 28 months, the three-year OS and PFS rates for the 27 patients were 54.4% and 27.8%, respectively. Patients who received concurrent chemoradiotherapy had better PFS than those who received radiotherapy alone (HR 0.16, 95% CI 0.03-0.81, P = .026). CONCLUSIONS: Definitive radiotherapy for locally advanced, unresectable, salivary gland cancers resulted in relatively good outcomes. Concurrent chemoradiotherapy was associated with better PFS than radiotherapy.

  3. Endoscopic-Assisted Tonsillectomy With Preemptive Hemostasis and Low-Output Bipolar Energy: A Strategy to Reduce Postoperative Hemorrhage. 国際誌

    Haruka Ota, Takuya Yoshida, Keita Suzuki, Kazutake Yagi, Kenjiro Higashi, Akira Ohkoshi, Yukio Katori

    Cureus 17 (5) e84933 2025年5月

    DOI: 10.7759/cureus.84933  

    詳細を見る 詳細を閉じる

    Introduction Tonsillectomy is a common surgical procedure in otolaryngology; however, postoperative hemorrhage remains a serious complication. Although novel hemostatic devices have been introduced, no definitive preventive strategy has been established. This study evaluated a standardized surgical approach combining preemptive hemostasis, reduced energy device output, and endoscopic assistance to minimize postoperative complications. Methods This single-center, non-randomized, observational cohort study included 137 patients aged 15 years or older who underwent extracapsular tonsillectomy between April 2018 and March 2025. Patients were grouped based on the time period of treatment: those who underwent conventional tonsillectomy between 2018 and 2021 comprised the Conventional Group (n = 85), and those who underwent a standardized procedure incorporating preemptive hemostasis and low-output energy devices between 2022 and 2025 comprised the Standardized Group (n = 52). Perioperative outcomes, postoperative hemorrhage rates, pain control, and hospital stay length were compared between groups using the Mann-Whitney U test and Fisher's exact test (p < 0.05 was considered significant). Results The Standardized Group showed a significantly lower postoperative hemorrhage rate (0% vs. 9.5%, p = 0.0236) and less intraoperative blood loss (0.42 ± 1.01 mL vs. 8.31 ± 26.7 mL, p = 0.0031) compared to the Conventional Group. Although operative time was longer (83.5 ± 33.3 min vs. 56.5 ± 23.8 min, p < 0.001), the Standardized Group had a shorter hospital stay (8.86 ± 1.24 days vs. 10.1 ± 1.15 days, p < 0.001) and required fewer rescue analgesic interventions (p = 0.0178). Conclusion The combination of preemptive hemostasis, reduced energy output, and endoscopic supervision significantly improved surgical outcomes, reduced complications, and enhanced the educational experience for junior surgeons. This protocol represents a standardized, cost-effective technique that enhances safety and surgical training.

  4. 鼻副鼻腔癌に対するTPF併用化学放射線療法についての検討

    登米 慧, 大越 明, 東 賢二郎, 石井 亮, 橋本 光, 大井 康平, 香取 幸夫

    日本耳鼻咽喉科頭頸部外科学会会報 128 (4) 654-654 2025年4月

    出版者・発行元: (一社)日本耳鼻咽喉科頭頸部外科学会

    ISSN:2436-5793

    eISSN:2436-5866

  5. Sensorineural hearing loss after concurrent chemoradiotherapy with high-dose cisplatin in head and neck cancer patients: Roles of nutrition and trace elements. 国際誌

    Akira Ohkoshi, Ryo Ishii, Kenjiro Higashi, Satoshi Toyoma, Tadahisa Shishido, Takaya Yamamoto, Hinako Harada, Ayako Nakanome, Yukio Katori

    Auris, nasus, larynx 52 (2) 141-145 2025年2月5日

    DOI: 10.1016/j.anl.2025.01.013  

    詳細を見る 詳細を閉じる

    OBJECTIVE: Sensorineural hearing loss (SNHL) is one of the most important adverse events of concurrent chemoradiotherapy (CCRT) with high-dose cisplatin for locally advanced head and neck squamous cell carcinoma (HNSCC). This retrospective study aimed to elucidate the effects of nutritional status and trace elements on the development of SNHL. METHODS: A retrospective review of 211 ears from 109 patients with HNSCC who underwent CCRT with high-dose cisplatin was performed. SNHL of each ear was classified according to Common Terminology Criteria for Adverse Events (CTCAE) version 5.0, and possible contributing factors were evaluated by univariate and multivariate analyses. Age, sex, primary site, clinical stage, treatment intent, smoking and drinking habits, history of hypertension, diabetes mellitus, body mass index, serum albumin, trace elements (Fe, Zn, Cu, Se), pretreatment average hearing level at 2-8 kHz, weight loss rate, cumulative cisplatin dose, and inner ear radiation dose were the variables evaluated. RESULTS: Ordinal logistic regression analysis showed that increased age, better pretreatment average hearing level at 2-8 kHz, and cumulative cisplatin dose were independent factors associated with the development of SNHL. CONCLUSION: Nutritional status and trace elements were not associated with the development of SNHL caused by CCRT with high-dose cisplatin.

  6. 高用量シスプラチン同時併用化学放射線治療による聴力障害

    大越 明, 東 賢二郎, 石井 亮, 香取 幸夫

    頭頸部癌 50 (2) 148-148 2024年5月

    出版者・発行元: (一社)日本頭頸部癌学会

    ISSN:1349-5747

    eISSN:1881-8382

  7. 姑息的放射線治療が奏功した喉頭摘出拒否の高齢者下咽頭進行癌の3症例

    石井 亮, 東 賢二郎, 宍戸 雅悠, 大越 明, 香取 幸夫

    頭頸部癌 50 (2) 207-207 2024年5月

    出版者・発行元: (一社)日本頭頸部癌学会

    ISSN:1349-5747

    eISSN:1881-8382

  8. Clinical characteristics and outcomes of persistent bacteremia in patients with head and neck cancer in a tertiary care hospital. 国際誌

    Shiori Kitaya, Hajime Kanamori, Ryo Ishii, Makoto Katsumi, Ryoukichi Ikeda, Kenjiro Higashi, Risako Kakuta, Akira Ohkoshi, Yukio Katori

    Frontiers in medicine 11 1406983-1406983 2024年

    DOI: 10.3389/fmed.2024.1406983  

    詳細を見る 詳細を閉じる

    INTRODUCTION: Compared to other cancers, research on bloodstream infection in head and neck cancer is scarce, lacking comparative studies on persistent versus transient bacteremia outcomes. METHODS: This retrospective survey examined patients with head and neck cancer undergoing blood culture at our center from June 2009 to May 2023. Blood culture-positive cases suspected of infection were divided into persistent bacteremia and transient bacteremia groups. We investigated their clinical, epidemiological, and microbiological features, including risk factors for persistent bacteremia and mortality. The primary outcome was 90-day mortality. RESULTS: In this 97-patient cohort, 14 (14%) cases were assigned to the persistent bacteremia group. Catheter-related bloodstream infections were the leading cause of infection in both groups, consistently contributing to a high proportion of overall bloodstream infections. The mortality rate was generally higher in the persistent bacteremia group than in the transient bacteremia group (odds ratio [OR], 2.6; 95% confidence interval [CI], 0.6-11.1), particularly in the non-clearance subgroup (OR, 9; 95% CI, 0.5-155.2). Pyogenic spondylitis was a key risk factor for persistent bacteremia, while hypoalbuminemia increased mortality. CONCLUSION: In patients with bacteremia and head and neck cancer, persistent bacteremia was associated with higher mortality than was transient bacteremia. Adittionally, bacteremia clearance in persistent bacteremia is thus crucial for prognostic improvement.

  9. 【気管食道科領域における手術教育の現状】東北大学におけるカダバーサージカルトレーニング

    東 賢二郎, 香取 幸大

    日本気管食道科学会会報 74 (5) 333-337 2023年10月

    出版者・発行元: (NPO)日本気管食道科学会

    ISSN:0029-0645

    eISSN:1880-6848

  10. Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials. 国際誌

    Tomohiko Ishikawa, Takenori Ogawa, Masahiro Shiihara, Hajime Usubuchi, Yuko Omori, Katsuya Hirose, Taito Itoh, Takuya Yoshida, Ayako Nakanome, Akira Okoshi, Kenjiro Higashi, Ryo Ishii, Masahiro Rokugo, Shun Wakamori, Yasunobu Okamura, Kengo Kinoshita, Yukio Katori, Toru Furukawa

    iScience 26 (5) 106695-106695 2023年5月19日

    DOI: 10.1016/j.isci.2023.106695  

    詳細を見る 詳細を閉じる

    Salivary gland cancers (SGCs) are heterogeneous tumors, and precision oncology represents a promising therapeutic approach; however, its impact on SGCs remains obscure. This study aimed to establish a translational model for testing molecular-targeted therapies by combining patient-derived organoids and genomic analyses of SGCs. We enrolled 29 patients, including 24 with SGCs and 5 with benign tumors. Resected tumors were subjected to organoid and monolayer cultures, as well as whole-exome sequencing. Organoid and monolayer cultures of SGCs were successfully established in 70.8% and 62.5% of cases, respectively. Organoids retained most histopathological and genetic profiles of their original tumors. In contrast, 40% of the monolayer-cultured cells did not harbor somatic mutations of their original tumors. The efficacy of molecular-targeted drugs tested on organoids depended on their oncogenic features. Organoids recapitulated the primary tumors and were useful for testing genotype-oriented molecular targeted therapy, which is valuable for precision medicine in patients with SGCs.

  11. 高用量シスプラチン併用化学放射線療法患者における高齢者総合機能評価の有用性

    宍戸 雅悠, 石井 亮, 東 賢二郎, 大越 明, 香取 幸夫

    頭頸部癌 49 (2) 130-130 2023年5月

    出版者・発行元: (一社)日本頭頸部癌学会

    ISSN:1349-5747

    eISSN:1881-8382

  12. 頭頸部癌に対する根治的化学放射線治療における尿中NAGによる腎障害予測

    石井 亮, 東 賢二郎, 宍戸 雅悠, 大越 明, 香取 幸夫

    頭頸部癌 49 (2) 134-134 2023年5月

    出版者・発行元: (一社)日本頭頸部癌学会

    ISSN:1349-5747

    eISSN:1881-8382

  13. Trismus after partial maxillectomy and radiotherapy: Free flap reconstruction versus prosthetic obturation. 国際誌

    Akira Ohkoshi, Ryo Ishii, Kenjiro Higashi, Ayako Nakanome, Kenichiro Ishikawa, Yukio Katori

    Auris, nasus, larynx 50 (2) 260-265 2023年4月

    DOI: 10.1016/j.anl.2022.05.016  

    詳細を見る 詳細を閉じる

    OBJECTIVE: Partial maxillectomy and postoperative radiotherapy are both risk factors associated with trismus. This retrospective study aimed to evaluate the incidence and severity of trismus in patients following partial maxillectomy with or without postoperative radiotherapy and to compare free flap reconstruction and prosthetic obturation. METHODS: A retrospective review of 40 oral cancer patients who underwent partial maxillectomy with or without postoperative radiotherapy was performed. Maximum interincisal distance recorded at least 6 months after surgery was classified according to a revised subjective-objective management-analytical (SOMA) scale and compared between the free flap reconstruction group (n = 12) and the prosthetic obturation group (n = 28). RESULTS: Trismus was observed in 16/40 (40%) patients, and severe trismus was observed in 4/40 (10%) patients. Although no significant difference in trismus grade was observed between the free flap reconstruction and prosthetic obturation groups, both severe trismus and radiation-induced osteonecrosis were only seen in the prosthetic obturation group with postoperative radiotherapy. CONCLUSION: Free flap reconstruction was preferable to prosthetic obturation to avoid severe trismus and radiation-induced osteonecrosis in patients who underwent both partial maxillectomy and postoperative radiotherapy.

  14. NST加算算定を契機とした栄養チーム診療の強化による頭頸部癌化学放射線療法患者への効果

    石井 亮, 玉山 咲紀, 古積 杏花, 東 賢二郎, 宍戸 雅悠, 香取 幸夫

    学会誌JSPEN 5 (Suppl.1) 545-545 2023年

    出版者・発行元: (一社)日本栄養治療学会

    eISSN:2434-4966

  15. Investigation of the diversity of human papillomavirus 16 variants and L1 antigenic regions relevant for the prevention of human papillomavirus-related oropharyngeal cancer in Japan. 国際誌

    Takuya Yoshida, Takenori Ogawa, Ayako Nakanome, Akira Ohkoshi, Ryo Ishii, Kenjiro Higashi, Tomohiko Ishikawa, Yukio Katori, Toru Furukawa

    Auris, nasus, larynx 49 (6) 1033-1041 2022年12月

    DOI: 10.1016/j.anl.2022.04.006  

    詳細を見る 詳細を閉じる

    OBJECTIVE: This study aimed to investigate the distribution of human papillomavirus 16 (HPV16) variants that contribute to the development of HPV-related oropharyngeal carcinoma (HPV-OPC) in the Japanese population and to evaluate genetic variations in the sequence encoding the L1 antigen region of the viral outer shell that is targeted by existing vaccines and is relevant for designing a prevention strategy to combat the exponential increase in HPV-OPC cases in Japan. METHODS: Seventy Japanese HPV-OPC patients treated at Tohoku University Hospital were included in the study. DNA was extracted from formalin-fixed, paraffin-embedded tissue samples. Polymerase chain reaction and direct nucleotide sequencing were performed to determine the nucleotide polymorphisms necessary for the classification of HPV16 variants and to assess genetic diversity in the HPV16 L1 antigen region, including the BC, DE, EF, FG, and HI loops. RESULTS: The most common variant of HPV16 was the A4 sublineage (88.6%), conventionally called the Asian type, followed by the A1/2/3 (10.0%) sublineage, classified as the European type. The only nonsynonymous substitution detected in the L1 antigen loop region was p.N181T in the EF loop, which was found in 28/70 (40%) cases. In contrast, no nonsynonymous substitutions were observed in the DE, FG, and HI loops, which are particularly important regions in the antigen loop targeted by existing HPV vaccines. CONCLUSION: The most common HPV16 variant in Japanese HPV-OPC patients was the A4 subtype. The L1 antigen region is highly conserved, suggesting sufficient efficacy of existing HPV vaccines. These findings provide important information that will aid in the design of an HPV16 infection control strategy using existing HPV vaccines to prevent the spread of HPV-OPC in Japan.

  16. Eustachian Tube Functions in Concurrent Chemoradiotherapy for Head and Neck Cancer Patients. 国際誌

    Akira Ohkoshi, Ryoukichi Ikeda, Jun Suzuki, Takaya Yamamoto, Ryo Ishii, Kenjiro Higashi, Shun Wakamori, Yuki Nakayama, Ayako Nakanome, Takenori Ogawa, Yukio Katori

    Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 74 (Suppl 3) 6307-6312 2022年12月

    DOI: 10.1007/s12070-021-03058-x  

    詳細を見る 詳細を閉じる

    Ototoxicity is a dose-limiting adverse event for concurrent chemoradiotherapy (CCRT) with high-dose cisplatin for locally advanced head and neck squamous cell carcinoma (HNSCC). Both irradiation to the Eustachian tube (ET) and weight loss are risk factors for patulous ET. The aim of this prospective, observational study was to elucidate the incidences of patulous ET conditions before and after CCRT in HNSCC patients by means of ET function tests. This prospective, observational study was conducted in 27 HNSCC patients who received CCRT with high-dose cisplatin, and ET function tests (sonotubometry and tubo-tympano-aerodynamic graphy) were performed before and 3 months after CCRT. Factors potentially affecting the incidence of patulous ET conditions after CCRT were evaluated. Of the 54 ears from 27 patients investigated, patulous ET conditions were observed in 12 ears (22.2%) from 9 patients (33.3%) before CCRT and 15 ears (27.8%) from 11 patients (40.7%) at 3 months after CCRT. Only patulous ET conditions before CCRT in each ear were significantly associated with patulous ET conditions after CCRT (p = 0.010). This is the first report to describe the incidences of patulous ET conditions before and after CCRT in HNSCC patients. HNSCC patients are potentially at higher risk of patulous ET.

  17. 下顎正中離断・経口蓋アプローチ法と経鼻内視鏡を併用した上咽頭悪性腫瘍の切除

    佐藤 悠歩, 東 賢二郎, 石井 亮, 中山 勇樹, 中目 亜矢子, 大越 明, 香取 幸夫

    頭頸部外科 32 (2) 185-190 2022年10月

    出版者・発行元: (NPO)日本頭頸部外科学会

    ISSN:1349-581X

    eISSN:1884-474X

  18. Endoscopic Resection of Nasal Mucosal Melanoma Using Temporary Transseptal Access. 国際誌

    Jun Suzuki, Kenjiro Higashi, Tomotaka Hemmi, Hiroyuki Ikushima, Yukio Katori

    Cureus 14 (7) e26904 2022年7月

    DOI: 10.7759/cureus.26904  

    詳細を見る 詳細を閉じる

    Nasal mucosal melanoma (NMM) is a rare tumor with a poor prognosis. Although an endoscopic resection of malignant nasal tumor now becomes a treatment of choice when the surgical margin can be secured, it is still controversial. We report three cases of NMM that was successfully removed en bloc with clear margins by endoscopic surgery with temporal transseptal access. Cases of a 78-year-old woman, an 83-year-old man, and an 81-year-old man with NMM arising from the inferior turbinate who underwent endoscopic resection of the tumor are discussed in detail. We made temporal transseptal access using septal mucosal flaps. We moved the nasal cavity-occupying tumor to the contralateral side to create a working space to perform endoscopic en bloc resections. This technique is simple yet effective and less invasive than open craniofacial resections for removing malignancies arising from the inferior turbinate.

  19. The geriatric-8 screening tool for predicting complications in older adults after surgery for locally advanced head and neck cancer with free flap reconstruction. 国際誌

    Yuki Nakayama, Akira Ohkoshi, Ryo Ishii, Kenjiro Higashi, Ayako Nakanome, Takenori Ogawa, Yukio Katori

    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 279 (5) 2565-2571 2022年5月

    DOI: 10.1007/s00405-021-07038-3  

    詳細を見る 詳細を閉じる

    PURPOSE: Radical surgery with free flap reconstruction for locally advanced head and neck cancer (HNC) is quite challenging for older adults. This retrospective study aimed to elucidate the usefulness of the geriatric-8 (G8) screening tool for predicting postoperative complications in older adults with HNC. METHODS: A retrospective review of 37 older adults with HNC who underwent radical surgery with free flap reconstruction and were assessed by the G8 screening tool was performed. Postoperative complications during hospitalization were classified according to the Clavien-Dindo classification, and possible contributing factors, including the G8 score, for major and minor complications were subjected to univariate and multivariate analyses. RESULTS: The appropriate G8 cut-off value for both major and minor complications was 12 (area under the curve 0.56 and 0.55, respectively). Multivariate logistic regression analysis showed that both smoking and lower G8 score (≤ 12) were independently associated with the severity of complications (p = 0.043, p = 0.034, respectively). CONCLUSIONS: The G8 was a possible predictor of major and minor complications in older adults with HNC who underwent radical surgery with free flap reconstruction.

  20. Serum selenium predicts achievement of full-dose cisplatin in concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: A prospective, observational study. 国際誌

    Akira Ohkoshi, Ryo Ishii, Shun Wakamori, Yuki Nakayama, Takuya Yoshida, Kenjiro Higashi, Ayako Nakanome, Takenori Ogawa, Yukio Katori

    Oral oncology 121 105475-105475 2021年10月

    DOI: 10.1016/j.oraloncology.2021.105475  

    詳細を見る 詳細を閉じる

    OBJECTIVE: Concurrent chemoradiotherapy (CCRT) with three-weekly high-dose cisplatin (100 mg/m2) is a standard treatment for locally advanced head and neck squamous cell carcinoma (HNSCC), but compliance with cisplatin is often poor due to various adverse events. The aim of this prospective, observational study was to determine the predictors of achievement of full-dose cisplatin. METHODS: A prospective, observational study was conducted involving 60 patients who received CCRT with three-weekly high-dose cisplatin (100 mg/m2) for locally advanced HNSCC. Possible predictors affecting compliance with cisplatin were subjected to univariate and multivariate logistic regression analyses. Age, sex, primary site, clinical stage, treatment intent, history of hypertension, diabetes mellitus, smoking and drinking habits, body mass index, creatinine clearance, serum albumin, controlling nutrition status, trace elements (Fe, Zn, Cu, Se), acute kidney injury, white blood cell count decrease, neutrophilia, and weight loss were the variables evaluated. RESULTS: Twenty-seven patients achieved full-dose cisplatin (300 mg/m2), and the other 33 patients did not. Multivariate logistic regression analysis showed that both mild renal dysfunction and selenium deficiency before treatment independently had negative impacts on achievement of full-dose cisplatin. CONCLUSIONS: As well as renal function, selenium deficiency is a potential therapeutic target for CCRT with high-dose cisplatin in HNSCC patients.

  21. Management of adenoid cystic carcinoma of the head and neck: a single-institute study with over 25-year follow-up. 国際誌

    Eiichi Ishida, Takenori Ogawa, Masahiro Rokugo, Tomohiko Ishikawa, Shun Wakamori, Akira Ohkoshi, Hajime Usubuchi, Kenjiro Higashi, Ryo Ishii, Ayako Nakanome, Yukio Katori

    Head & face medicine 16 (1) 14-14 2020年7月2日

    DOI: 10.1186/s13005-020-00226-2  

    詳細を見る 詳細を閉じる

    BACKGROUND: Adenoid cystic carcinoma is a rare malignant tumor arising from exocrine glands such as the major and minor salivary glands of the paranasal sinuses or the external auditory canal. Although multiple retrospective clinical studies of ACC have been reported to date, clinical questions, such as 1) long-term prognosis beyond 20 years, 2) usefulness and suitability for treatment of therapeutic interventions, 3) therapeutic goal to aim for, and 4) prognosis by recurrence sites, are still unclear. METHODS: To improve understanding and management of adenoid cystic carcinoma of the head and neck (ACC), a retrospective study with 58 new ACC cases between 1991 and 2016 was performed. The median observation period was 66.8 months (range 3-316 months). The overall clinical stages were as follows: I, 6.9%; II, 25.9%; III, 19.0%; and IV, 48.2%. Histology was cribriform/tubular type (C-T type) in 62.0% and solid type in 27.5%. The main treatment strategy was definitive surgery, which was performed in 75.2% of cases. RESULTS: Overall 10-year, 20-year, and 25-year survivals were 63.7, 27.3, and 20.0%, respectively. Similarly, disease-specific survival (DSSs) was 65.7, 51.2, and 38.4%, respectively, and disease-free survival was 25.2, 9.4, and 9.4%, respectively. Conducting surgery (HR: 0.19, 95% CI: 0.06-0.61, p = 0.005) and C-T type (HR: 0.32, 95% CI: 0.11-0.93, p = 0.036) were independent prognostic predictors of DSS. DSS was significantly prolonged after salvage surgery for both locoregional recurrence (p = 0.004) and lung metastatic recurrence (p = 0.012, vs best supportive care). CONCLUSIONS: In ACC cases, both initial surgical treatment and repetitive surgical resection of resectable recurrent lesions, including both locoregional and lung metastases, resulted in longer survival. The major goal of treatment for ACC may be long-term survival including cancer-bearing survival, resulting in either natural death or intercurrent-disease death, since judging cure of ACC is almost impossible. TRIAL REGISTRATION: Retrospectively registered.

  22. Long-Term Outcomes of Patients with Squamous Cell Carcinoma of the Temporal Bone after Concomitant Chemoradiotherapy. 国際誌

    Kiyoto Shiga, Katsunori Katagiri, Daisuke Saitoh, Takenori Ogawa, Kenjiro Higashi, Hisanori Ariga

    Journal of neurological surgery. Part B, Skull base 79 (Suppl 4) S316-S321 2018年10月

    DOI: 10.1055/s-0038-1651522  

    詳細を見る 詳細を閉じる

    Objectives  This article aims to clarify the long-term outcomes of patients with squamous cell carcinoma of the temporal bone who underwent concomitant chemoradiotherapy (CCRT). Design and Setting  The study design was a retrospective chart review. Patients and Methods  From December 2001 to June 2014, 23 patients with cancer of the temporal bone who were treated by CCRT at the Tohoku University Hospital and the Iwate Medical University Hospital were enrolled in this study. For advanced cancer of the temporal bone, a modified docetaxel, cisplatin, and 5-fluorouracil (TPF) regimen was used for CCRT. The long-term outcomes, including prognoses and late complications, were analyzed after CCRT of patients with cancers of the temporal bone. Results  The main long-term complications were stenosis of the external auditory canal and conductive hearing loss. No harmful late complications were observed in these patients. Disease-specific survival rates were 84.9% for all patients, 100% for patients of stage I, II, and III ( n  = 10), and 75.5% for patients of stage IV ( n  = 13) at 5 years. Conclusions  Our study showed that CCRT is an effective treatment choice for squamous cell carcinoma of the temporal bone. Furthermore, CCRT using the TPF regimen is a safe and effective initial treatment for patients with advanced cancers of the temporal bone.

  23. 頭頸部癌における高齢者機能評価スクリーニングツールの有用性

    石井 亮, 小川 武則, 高橋 昌宏, 嵯峨井 俊, 中目 亜矢子, 大越 明, 東 賢二郎, 白倉 真之, 香取 幸夫

    頭頸部外科 28 (1) 55-61 2018年6月

    出版者・発行元: (NPO)日本頭頸部外科学会

    ISSN:1349-581X

    eISSN:1884-474X

  24. A Novel SDHB IVS2-2A>C Mutation Is Responsible for Hereditary Pheochromocytoma/Paraganglioma Syndrome.

    Mie Yamanaka, Kiyoto Shiga, Sho Fujiwara, Yasuhiko Mizuguchi, Sari Yasuda, Kota Ishizawa, Yuriko Saiki, Kenjiro Higashi, Takenori Ogawa, Noriko Kimura, Akira Horii

    The Tohoku journal of experimental medicine 245 (2) 99-105 2018年6月

    DOI: 10.1620/tjem.245.99  

    詳細を見る 詳細を閉じる

    Pheochromocytomas and paragangliomas are neuroendocrine tumors which arise from adrenal medulla, and sympathetic or parasympathetic nerves, respectively. Hereditary cases afflicted by both or either pheochromocytomas and paragangliomas have been reported: these are called hereditary pheochromocytoma/paraganglioma syndromes (HPPS). Many cases of HPPS are caused by mutations of one of the succinate dehydrogenase (SDH) genes; mainly SDHB and SDHD that encode subunits for the mitochondrial respiratory chain complex II. In this study, we investigated mutations of SDH genes in six HPPS patients from four Japanese pedigrees using peripheral blood lymphocytes (from one patient with pheochromocytoma and five patients with neck paraganglioma) and tumor tissues (from two patients with paraganglioma). Results showed that all of these pedigrees harbor germline mutations in one of the SDH genes. In two pedigrees, a novel IVS2-2A>C mutation in SDHB, at the acceptor-site in intron 2, was found, and the tumor RNA of the patient clearly showed frameshift caused by exon skipping. Each of the remaining two pedigrees harbors a reported missense mutation, R242H in SDHB or G106D in SDHD. Importantly, all these mutations are heterozygous in constitutional DNAs, and two-hit mutations were evident in tumor DNAs. We thus conclude that the newly identified IVS2-2A>C mutation in SDHB is responsible for HPPS. The novel mutation revealed by our study may contribute to improvement of clinical management for patients with HPPS.

  25. 頭頸部原発骨肉腫の6例

    嵯峨井 俊, 小川 武則, 臼渕 肇, 小嶋 郁穂, 村田 隆紀, 阪本 真弥, 高橋 昌宏, 西條 憲, 加藤 健吾, 中目 亜矢子, 大越 明, 東 賢二郎, 石井 亮, 香取 幸夫

    頭頸部外科 27 (3) 379-385 2018年2月

    出版者・発行元: (NPO)日本頭頸部外科学会

    ISSN:1349-581X

    eISSN:1884-474X

  26. Simple laryngeal suspension procedure by suturing the digastric muscle to the periosteum of the mandible in neck dissection for tongue cancer. 国際誌

    Akira Ohkoshi, Takenori Ogawa, Shun Sagai, Ayako Nakanome, Kenjiro Higashi, Ryo Ishii, Kengo Kato, Yukio Katori

    American journal of otolaryngology 39 (2) 77-81 2018年

    DOI: 10.1016/j.amjoto.2018.01.008  

    詳細を見る 詳細を閉じる

    PURPOSE: In this article, a simple, new laryngeal suspension procedure is described. The effect of hyoid bone suspension by suturing the digastric muscle to the periosteum of the mandible is analyzed. MATERIALS AND METHODS: To elucidate the effect of hyoid bone suspension, CT scans of 26 patients who underwent ipsilateral neck dissection with primary resection of tongue cancer were retrospectively reviewed, and the distance between the hyoid bone and the mandible was measured on the operated and unoperated sides of the neck. A total of 14 patients who underwent suturing of the digastric muscle to the mandible (digastric muscle-sutured group) and the 12 patients who did not (control group) were compared. RESULTS: In the digastric muscle-sutured group, the average distance between the hyoid bone and the mandible was significantly smaller on the operated side (17.8 ± 0.57 mm) than on the unoperated side (19.8 ± 0.93 mm; p < 0.05). In the control group, there was no significant difference between the operated side (21.0 ± 1.42 mm) and the unoperated side (19.7 ± 1.39 mm). The difference in the distance between the operated and unoperated sides was significantly larger in the digastric muscle-sutured group (1.97 ± 0.79 mm) than in the control group (-1.32 ± 0.61; p < 0.05). CONCLUSIONS: It was shown for the first time that suturing of the digastric muscle to the periosteum of the mandible in neck dissection with primary resection of tongue cancer resulted in hyoid bone suspension. This simple procedure can be useful for laryngeal suspension.

  27. 頭蓋底浸潤鼻副鼻腔悪性腫瘍に対する治療戦略

    小川 武則, 小嶋 郁穂, 村田 隆紀, 阪本 真弥, 岸田 佳太, 高橋 紀善, 松下 晴雄, 荒川 一弥, 野村 和弘, 中目 亜矢子, 大越 明, 東 賢二郎, 石井 亮, 嵯峨井 俊, 神宮 啓一, 香取 幸夫

    頭頸部癌 43 (4) 409-414 2017年12月

    出版者・発行元: (一社)日本頭頸部癌学会

    ISSN:1349-5747

    eISSN:1881-8382

  28. MRIで悪性腫瘍箇所を同定し得た耳下腺多形腺腫由来癌の1例

    若盛 隼, 小川 武則, 臼渕 肇, 阪本 真弥, 小嶋 郁穂, 村田 隆紀, 嵯峨井 俊, 中目 亜矢子, 大越 明, 東 賢二郎, 石井 亮, 白倉 真之, 石川 智彦, 香取 幸夫

    頭頸部外科 26 (3) 389-393 2017年2月

    出版者・発行元: (NPO)日本頭頸部外科学会

    ISSN:1349-581X

    eISSN:1884-474X

  29. Clinicopathological features of melanotic neuroectodermal tumor of infancy: Report of two cases. 国際誌

    Kenjiro Higashi, Takenori Ogawa, Masaei Onuma, Hajime Usubuchi, Yoshimichi Imai, Iori Takata, Hiroshi Hidaka, Mika Watanabe, Yoji Sasahara, Shigeto Koyama, Shigeo Kure, Yukio Katori

    Auris, nasus, larynx 43 (4) 451-4 2016年8月

    DOI: 10.1016/j.anl.2015.10.010  

    詳細を見る 詳細を閉じる

    Melanotic neuroectodermal tumor of infancy (MNTI) is an extremely rare, pigmented neoplastic entity of neural crest origin. Histological and immunohistochemical profiles indicate the presence of two components, small rounded neuroblast-like cellular areas and areas with large melanin-containing cells which consist of combination of neural, melanocytic, and epithelial cell types. Here we present two interesting cases of infants with MNTI which have different clinicopathological features. The first case is a 3-month-old female with rapidly growing MNTI involving the lacrimal sac and inferior wall of the orbital cavity, treated with total maxillectomy without orbital exenteration followed by chemotherapy. The second case is a 7-month-old male with slow-growing maxillary MNTI treated with complete surgical excision. In the female patient, histological findings revealed a predominance of neuroblast-like cellular areas and a high Ki67 index indicating rapid cellular proliferation. In the male patient however, large melanin-containing cells were dominant in this slow-growing tumor. These findings support the presence of two different types of MNTI, rapid-growing and slow-growing types, determined by the component of neuroblast-like cellular areas.

  30. 超高齢者に対して喉頭全摘術を施行した2症例

    石井 亮, 小川 武則, 加藤 健吾, 中目 亜矢子, 東 賢二郎, 嵯峨井 俊, 渡邊 健一, 香取 幸夫

    頭頸部外科 25 (3) 319-323 2016年2月

    出版者・発行元: (NPO)日本頭頸部外科学会

    ISSN:1349-581X

    eISSN:1884-474X

  31. Nasal cavity epithelioid hemangioendothelioma invading the anterior skull base. 国際誌

    Shogo Ogita, Toshiki Endo, Kazuhiro Nomura, Takenori Ogawa, Mika Watanabe, Kenjiro Higashi, Yukio Katori, Teiji Tominaga

    Surgical neurology international 7 53-53 2016年

    DOI: 10.4103/2152-7806.181902  

    詳細を見る 詳細を閉じる

    BACKGROUND: Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor that frequently occurs in soft tissues. Patients suffer from local recurrence and remote metastasis because of its malignant potential. Here, we present a rare case of EHE that originated from nasal cavity and invaded intracranially through the anterior skull base. CASE DESCRIPTION: This is a 27-year-old woman who presented a local physician with intermittent epistaxis and a facial pain around her nose. Preoperative studies demonstrated that the tumor invaded into anterior skull base and the dura matter. Therefore, we performed combined skull base and transnasal surgery, which achieved complete resection of the tumor. Postoperative course of the patient was uneventful. No recurrence or distant metastasis was observed in the patient for 2 years following the radical resection. CONCLUSIONS: To date, four cases of EHE in the nasal cavity were reported. This is the first case in which EHE demonstrated invasive potentials with intracranial extension. Radical surgical resection plays an important role for better management of invasive paranasal EHE.

  32. Central-part laryngectomy is a useful and less invasive surgical procedure for resolution of intractable aspiration. 国際誌

    Ai Kawamoto, Yukio Katori, Yohei Honkura, Risako Kakuta, Kenjiro Higashi, Masaki Ogura, Makiko Miyazaki, Kazuya Arakawa, Kazutaka Kashima, Yukinori Asada, Kazuto Matsuura

    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 271 (5) 1149-55 2014年5月

    DOI: 10.1007/s00405-013-2725-4  

    詳細を見る 詳細を閉じる

    A novel narrow-field laryngectomy procedure known as central-part laryngectomy (CPL) for less invasive laryngeal diversion in patients with intractable aspiration is introduced. We conducted retrospective case reviews of 15 patients who underwent CPL. In this procedure, an area of the glottis including the mid-part of the thyroid cartilage and cricoid cartilage is removed to separate the digestive tract from the air way. The lateral part of the thyroid cartilage, the entire hypopharyngeal mucosa and epiglottis are preserved. The superior laryngeal vessels and nerve are not invaded. All fifteen patients were relieved of aspiration without major complications. In good accordance with cutting of the cricopharyngeal muscles and removal of the cricoid cartilage, postoperative videofluoroscopy demonstrated smooth passages of barium. Ten of 12 patients who had hoped to resume oral food intake became able to do so after CPL and two others also achieved partial oral deglutition. CPL is a useful procedure for treatment of intractable aspiration and offers considerable advantages over other laryngotracheal diversion procedures from the view point of oral food intake.

  33. Recurrent chondro-osseous respiratory epithelial adenomatoid hamartoma of the nasal cavity in a child. 国際誌

    Kazuhiro Nomura, Takeshi Oshima, Atsuko Maki, Takahiro Suzuki, Kenjiro Higashi, Mika Watanabe, Toshimitsu Kobayashi

    Ear, nose, & throat journal 93 (1) E29-31 2014年1月

    eISSN:1942-7522

    詳細を見る 詳細を閉じる

    Chondro-osseous respiratory epithelial adenomatoid hamartoma (COREAH) is an extremely rare type of hamartoma. To the best of our knowledge, only 1 case has been previously reported. A 7-year-old girl presented with a case of COREAH of the bilateral nasal cavities. Polypous masses in both nasal cavities were resected endoscopically, and they were histologically diagnosed as COREAH. A large polypous mass recurred 1 year postsurgically on the right side only. A second endoscopic surgery was performed, and the lesion was confirmed to be recurrent COREAH. Hamartoma of the nasal cavity is rare and is generally considered to be self-limiting. This case suggests that nasal hamartomas may have neoplastic characteristics, and therefore require complete resection.

  34. 重度誤嚥に対して喉頭中央部切除術を施行した2症例

    香取 幸夫, 小倉 正樹, 東 賢二郎, 堀 容子, 角田 梨沙子, 高梨 芳崇, 小林 俊光

    嚥下医学 1 (1) 184-190 2012年2月

    出版者・発行元: 日本嚥下医学会

    ISSN:2186-3199

  35. 頭頸部癌治療におけるエコーガイド下上腕末梢穿刺中心静脈カテーテルの有用性

    鈴木 淳, 加藤 健吾, 東 賢二郎, 大島 英敏, 小川 武則, 鈴木 貴博, 志賀 清人, 小林 俊光

    耳鼻咽喉科・頭頸部外科 83 (7) 517-522 2011年6月

    出版者・発行元: (株)医学書院

    ISSN:0914-3491

    eISSN:1882-1316

    詳細を見る 詳細を閉じる

    2010年3月に耳鼻咽喉科職歴12年以内の耳鼻咽喉科医22名を対象に、中心静脈カテーテル(CVC)経験症例数とエコーガイド下穿刺吸引細胞診(UG-FNAC)経験症例数、CVC穿刺部位の選択・選択理由についてアンケート調査した。職歴は平均5.6(1~12)年、初期臨床研修を10名(45%)が受けていた。大腿静脈穿刺経験が10例以上ある人は82%、内頸静脈穿刺は14%、鎖骨下静脈穿刺は14%であった。UG-上腕末梢穿刺中心静脈カテーテル(PICC)は穿刺時合併症が生ぜず確実な留置が可能であった。

  36. Glomangiopericytoma of the nasal cavity. 国際誌

    Kenjiro Higashi, Kazuhiro Nakaya, Mika Watanabe, Ryoukichi Ikeda, Takahiro Suzuki, Takeshi Oshima, Toshimitsu Kobayashi

    Auris, nasus, larynx 38 (3) 415-7 2011年6月

    DOI: 10.1016/j.anl.2010.08.009  

    詳細を見る 詳細を閉じる

    Glomangiopericytoma is a rare tumor arising from the pericytes surrounding capillaries, and accounts for less than 0.5% of all sinonasal tumors. A 60-year-old male patient presented with a glomangiopericytoma of the nasal cavity manifesting as nasal obstruction and epistaxis, which was treated successfully with endoscopic excision. Histological examination showed multiplication of spindle-shaped to oval cells which reacted strongly to immunostaining for α-smooth muscle actin. Glomangiopericytoma is categorized as a borderline low malignancy tumor, which tends to recurrence. Strict follow-up is required, especially if complete resection is not achieved.

  37. A case of myoepithelioma of the nasal cavity. 国際誌

    Kazuhiro Nakaya, Takeshi Oshima, Mika Watanabe, Hiroshi Hidaka, Toshiaki Kikuchi, Kenjiro Higashi, Yohei Honkura, Yosuke Hara, Toshimitsu Kobayashi

    Auris, nasus, larynx 37 (5) 640-3 2010年10月

    DOI: 10.1016/j.anl.2010.03.004  

    詳細を見る 詳細を閉じる

    Myoepithelioma is a rare tumor, most frequently located in the salivary gland. Case reports of extra-salivary myoepithelioma are sporadic, with only one case in the nasal cavity. A 68-year-old male patient presented with a myoepithelioma of the nasal cavity manifesting as nasal obstruction and epistaxis, which was treated successfully with endoscopic excision. Histological examination revealed myoepithelial cells and myxoid stroma, which confirmed the diagnosis of myoepithelioma. The behavioral pattern is similar to if not identical with that of the mixed tumor, pleomorphic adenoma, which is benign, but the potential for recurrence is always present, especially if complete resection is not achieved.

︎全件表示 ︎最初の5件までを表示

MISC 30

  1. 自己記入式CGAによる頭頸部がん患者の高齢に関連するアウトカムの予測

    石井 亮, 大越 明, 中山 勇樹, 東 賢二郎, 中目 亜矢子, 香取 幸夫

    日本癌治療学会学術集会抄録集 60回 P60-3 2022年10月

    出版者・発行元: (一社)日本癌治療学会

  2. 自己記入式CGAによる頭頸部がん患者の高齢に関連するアウトカムの予測

    石井 亮, 大越 明, 中山 勇樹, 東 賢二郎, 中目 亜矢子, 香取 幸夫

    日本癌治療学会学術集会抄録集 60回 P60-3 2022年10月

    出版者・発行元: (一社)日本癌治療学会

  3. 下顎正中離断・経口蓋アプローチ法と経鼻内視鏡を併用した上咽頭悪性腫瘍の切除

    佐藤 悠歩, 東 賢二郎, 石井 亮, 中山 勇樹, 中目 亜矢子, 大越 明, 香取 幸夫

    頭頸部外科 32 (2) 185-190 2022年10月

    出版者・発行元: (NPO)日本頭頸部外科学会

    ISSN: 1349-581X

    eISSN: 1884-474X

  4. 頭頸部外来における自己記入式CGAの導入

    石井 亮, 大越 明, 東 賢二郎, 中目 亜矢子, 中山 勇樹, 香取 幸夫

    頭頸部癌 48 (2) 189-189 2022年5月

    出版者・発行元: (一社)日本頭頸部癌学会

    ISSN: 1349-5747

    eISSN: 1881-8382

  5. 頭頸部外来における自己記入式CGAの導入

    石井 亮, 大越 明, 東 賢二郎, 中目 亜矢子, 中山 勇樹, 香取 幸夫

    頭頸部癌 48 (2) 189-189 2022年5月

    出版者・発行元: (一社)日本頭頸部癌学会

    ISSN: 1349-5747

    eISSN: 1881-8382

  6. 頭頸部再建手術における高齢者機能評価スクリーニングツール(G8)の合併症予測に対する有用性

    中山 勇樹, 大越 明, 石井 亮, 中目 亜矢子, 東 賢二郎, 香取 幸夫

    日本気管食道科学会会報 73 (2) s22-s22 2022年4月

    出版者・発行元: (NPO)日本気管食道科学会

    ISSN: 0029-0645

    eISSN: 1880-6848

  7. 唾液腺導管癌の患者由来オルガノイド細胞株を用いた個別化医療モデル

    石川 智彦, 中目 亜矢子, 大越 明, 東 賢二郎, 石井 亮, 六郷 正博, 若盛 隼, 吉田 拓矢, 小川 武則, 古川 徹, 香取 幸夫

    日本耳鼻咽喉科学会会報 124 (4) 591-591 2021年4月

    出版者・発行元: (一社)日本耳鼻咽喉科頭頸部外科学会

    ISSN: 0030-6622

    eISSN: 1883-0854

  8. 東北大学における下咽頭癌200例の臨床統計

    中目 亜矢子, 小川 武則, 嵯峨井 俊, 大越 明, 東 賢二郎, 石井 亮, 香取 幸夫

    耳鼻咽喉科展望 62 (補冊1) 22-23 2019年6月

    出版者・発行元: 耳鼻咽喉科展望会

    ISSN: 0386-9687

    eISSN: 1883-6429

  9. 東北大学における舌癌を除く口腔癌179例の臨床統計

    小川 武則, 中目 亜矢子, 石井 亮, 嵯峨井 俊, 大越 明, 東 賢二郎, 加藤 健吾, 香取 幸夫

    耳鼻咽喉科展望 62 (補冊1) 48-49 2019年6月

    出版者・発行元: 耳鼻咽喉科展望会

    ISSN: 0386-9687

    eISSN: 1883-6429

  10. 頭頸部腺様嚢胞癌63例の臨床統計

    石田 英一, 石井 亮, 六郷 正博, 東 賢二郎, 石川 智彦, 佐藤 亜矢子, 大越 明, 小川 武則, 香取 幸夫

    日本耳鼻咽喉科学会会報 121 (4) 542-542 2018年4月

    出版者・発行元: (一社)日本耳鼻咽喉科学会

    ISSN: 0030-6622

    eISSN: 1883-0854

  11. 東北大学病院における喉頭扁平上皮癌の臨床統計

    東 賢二郎, 小川 武則, 石井 亮, 中目 亜矢子, 渡邊 健一, 香取 幸夫

    耳鼻咽喉科展望 60 (補冊1) 20-21 2017年6月

    出版者・発行元: 耳鼻咽喉科展望会

    ISSN: 0386-9687

    eISSN: 1883-6429

  12. 東北大学における若年者舌癌の治療の検討

    石井 亮, 小川 武則, 白倉 真之, 東 賢二郎, 大越 明, 嵯峨井 俊, 香取 幸夫

    耳鼻咽喉科展望 60 (補冊1) 42-43 2017年6月

    出版者・発行元: 耳鼻咽喉科展望会

    ISSN: 0386-9687

    eISSN: 1883-6429

  13. 耳下腺および副咽頭間隙腫瘍をはじめとする頭頸部腫瘍に対するcore needle biopsyの有用性

    石井 亮, 小川 武則, 臼渕 肇, 白倉 真之, 東 賢二郎, 中目 亜矢子, 大越 明, 嵯峨井 俊, 香取 幸夫

    頭頸部癌 43 (2) 188-188 2017年5月

    出版者・発行元: (一社)日本頭頸部癌学会

    ISSN: 1349-5747

    eISSN: 1881-8382

  14. 当科における下咽頭食道重複癌の検討

    東 賢二郎, 小川 武則, 嵯峨井 俊, 中目 亜矢子, 大越 明, 石井 亮, 香取 幸夫

    頭頸部癌 43 (2) 274-274 2017年5月

    出版者・発行元: (一社)日本頭頸部癌学会

    ISSN: 1349-5747

    eISSN: 1881-8382

  15. Treatment strategy for sinonasal malignant tumor with skull base invasion

    Takenori Ogawa, Ikuho Kojima, Takaki Murata, Maya Sakamoto, Keita Kishida, Noriyoshi Takahashi, Haruo Matsushita, Kazuya Arakawa, Kazuhiro Nomura, Ayako Nakanome, Akira Okoshi, Kenjiro Higashi, Ryo Ishii, Shun Sagai, Keiichi Jingu, Yukio Katori

    Japanese Journal of Head and Neck Cancer 43 409-414 2017年1月1日

    DOI: 10.5981/jjhnc.43.409  

    ISSN: 1349-5747

  16. 咽頭癌化学放射線療法における絶食期間および胃瘻離脱困難の検討

    石井 亮, 白倉 真之, 平野 愛, 鹿島 和孝, 東 賢二郎, 大越 明, 中目 亜矢子, 嵯峨井 俊, 加藤 健吾, 小川 武則, 香取 幸夫

    頭頸部癌 42 (2) 183-183 2016年5月

    出版者・発行元: (一社)日本頭頸部癌学会

    ISSN: 1349-5747

    eISSN: 1881-8382

  17. 下咽頭・食道重複癌に対する治療強度と忍容性

    石井 亮, 小川 武則, 嵯峨井 俊, 大越 明, 東 賢二郎, 香取 幸夫

    日本気管食道科学会会報 67 (2) s22-s22 2016年4月

    出版者・発行元: (NPO)日本気管食道科学会

    ISSN: 0029-0645

    eISSN: 1880-6848

  18. 東北大学における原発不明癌の検討

    東 賢二郎, 小川 武則, 加藤 健吾, 中目 亜矢子, 石井 亮, 香取 幸夫

    耳鼻咽喉科展望 58 (補冊1) 42-43 2015年9月

    出版者・発行元: 耳鼻咽喉科展望会

    ISSN: 0386-9687

    eISSN: 1883-6429

  19. 頸部郭清術後の内頸静脈閉塞についての検討

    石井 亮, 小川 武則, 中目 亜矢子, 東 賢二郎, 嵯峨井 俊, 野村 和弘, 香取 幸夫

    頭頸部癌 41 (2) 227-227 2015年5月

    出版者・発行元: (一社)日本頭頸部癌学会

    ISSN: 1349-5747

    eISSN: 1881-8382

  20. 遠隔転移を来した唾液腺多型腺腫の3例

    嵯峨井 俊, 小川 武則, 中目 亜矢子, 東 賢二郎, 石井 亮, 臼渕 肇, 渡邊 健一, 香取 幸夫

    日本耳鼻咽喉科学会会報 118 (4) 491-491 2015年4月

    出版者・発行元: (一社)日本耳鼻咽喉科学会

    ISSN: 0030-6622

    eISSN: 1883-0854

  21. 頭頸部非扁平上皮癌におけるEGFR発現

    東 賢二郎, 小川 武則, 中目 亜矢子, 石井 亮, 香取 幸夫

    日本耳鼻咽喉科学会会報 118 (4) 564-564 2015年4月

    出版者・発行元: (一社)日本耳鼻咽喉科学会

    ISSN: 0030-6622

    eISSN: 1883-0854

  22. 咽頭食道重複がん治療における嚥下機能

    小川 武則, 中目 亜矢子, 嵯峨井 俊, 東 賢二郎, 石井 亮, 河本 愛, 荒川 一弥, 加藤 健吾, 香取 幸夫

    日本耳鼻咽喉科学会会報 118 (4) 574-574 2015年4月

    出版者・発行元: (一社)日本耳鼻咽喉科学会

    ISSN: 0030-6622

    eISSN: 1883-0854

  23. 遠隔転移を来した頭蓋底浸潤エナメル上皮腫の1例

    中目 亜矢子, 小川 武則, 臼渕 肇, 石井 亮, 東 賢二郎, 嵯峨井 俊, 香取 幸夫

    日本耳鼻咽喉科学会会報 118 (4) 594-594 2015年4月

    出版者・発行元: (一社)日本耳鼻咽喉科学会

    ISSN: 0030-6622

    eISSN: 1883-0854

  24. 下咽頭喉頭頸部食道摘出後の高度狭窄に対し、内視鏡下バルーン拡張術が有用であった1例

    小川 武則, 加藤 健吾, 高田 雄介, 東 賢二郎, 香取 幸夫

    嚥下医学 3 (2) 298-299 2014年9月

    出版者・発行元: 日本嚥下医学会

    ISSN: 2186-3199

  25. 内頸動脈系から栄養される上顎癌の治療戦略

    小川 武則, 村田 隆紀, 中目 亜矢子, 東 賢二郎, 石井 亮, 加藤 健吾, 渡邊 健一, 香取 幸夫

    頭頸部癌 40 (2) 172-172 2014年5月

    出版者・発行元: (一社)日本頭頸部癌学会

    ISSN: 1349-5747

    eISSN: 1881-8382

  26. 頭頸部癌患者に対する化学療法施行時のB型肝炎スクリーニングおよび肝機能の評価

    中目 亜矢子, 小川 武則, 加藤 健吾, 渡邊 健一, 東 賢二郎, 石井 亮, 香取 幸夫

    頭頸部癌 40 (2) 182-182 2014年5月

    出版者・発行元: (一社)日本頭頸部癌学会

    ISSN: 1349-5747

    eISSN: 1881-8382

  27. 下咽頭癌・食道癌の異時性重複癌に対し、両側下咽頭部分切除、ELPSを施行した一例

    石井 亮, 小川 武則, 渡邊 健一, 中目 亜矢子, 東 賢二郎, 加藤 健吾, 志賀 清人, 香取 幸夫

    頭頸部癌 40 (2) 197-197 2014年5月

    出版者・発行元: (一社)日本頭頸部癌学会

    ISSN: 1349-5747

    eISSN: 1881-8382

  28. 切開排膿術を施行した小児頸部リンパ節膿瘍の7症例

    東 賢二郎, 香取 幸夫

    小児耳鼻咽喉科 32 (2) 139-139 2011年5月

    出版者・発行元: 日本小児耳鼻咽喉科学会

    ISSN: 0919-5858

    eISSN: 2186-5957

  29. 手術治療を要した乳児の喉頭蓋嚢腫の3症例

    香取 幸夫, 小倉 正樹, 堀 容子, 角田 梨沙子, 東 賢二郎

    小児耳鼻咽喉科 32 (2) 154-154 2011年5月

    出版者・発行元: 日本小児耳鼻咽喉科学会

    ISSN: 0919-5858

    eISSN: 2186-5957

  30. 誤嚥防止を目的とする低侵襲な喉頭摘出術

    香取 幸夫, 小倉 正樹, 堀 容子, 東 賢二郎

    日本耳鼻咽喉科学会会報 114 (4) 339-339 2011年4月

    出版者・発行元: (一社)日本耳鼻咽喉科学会

    ISSN: 0030-6622

    eISSN: 1883-0854

︎全件表示 ︎最初の5件までを表示

講演・口頭発表等 11

  1. 当院における頭頸部癌孤立性肺転移の検討

    東 賢二郎

    第33回 日本頭頸部外科学会総会・学術講演会 2024年2月1日

  2. 鼻内より閉鎖し得た硬口蓋穿孔の1例

    東 賢二郎

    第59回 日本鼻科学会総会・学術講演会 2020年10月10日

  3. 頭頸部扁平上皮癌におけるマイクロRNAとPD-L1の検討

    東 賢二郎

    第66回 日本耳鼻咽喉科学会東北地方部会連合学術講演会 2018年7月

  4. 当科における下咽頭食道重複癌の検討

    東 賢二郎

    第41回 日本頭頸部癌学会 2017年6月

  5. 頭頸部非扁平上皮癌におけるEGFR発現

    東 賢二郎

    第116回 日本耳鼻咽喉科学会 総会・学術講演会 2015年5月

  6. 東北大学病院における喉頭扁平上皮癌の臨床統計

    東 賢二郎

    第20回 北日本頭頸部癌治療研究会 2014年10月25日

  7. Clinicopathological features of Melanotic neuroectodermal tumor of infancy : report of two cases.

    Kenjiro Higashi

    5th World Congress – IFHNOS and Annual Meeting AHNS 2014年7月

  8. 外耳道扁平上皮癌放射線化学療法後の聴力に関する検討

    東 賢二郎

    第23回 日本耳科学会 総会・学術講演会 2013年11月

  9. 東北大学における原発不明癌の検討

    第19回 北日本頭頸部癌治療研究会 2013年10月26日

  10. 切開排膿術を施行した小児頸部リンパ節膿瘍の7症例

    東 賢二郎

    第 6 回 日本小児耳鼻咽喉科学会総会・学術講演会 2011年6月16日

  11. Glomangiopericytomaの1例

    東 賢二郎

    日本鼻科学会総会・学術講演会 2010年8月27日

︎全件表示 ︎最初の5件までを表示